De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study

J. M. Simons*, L. B. Koppert, E. J.T. Luiten, C. C. van der Pol, S. Samiei, J. H.W. de Wilt, S. Siesling, M. L. Smidt

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

24 Citations (Scopus)
10 Downloads (Pure)

Abstract

Purpose: An overall trend is observed towards de-escalation of axillary surgery in patients with breast cancer. The objective of this study was to evaluate this trend in patients treated with neoadjuvant systemic therapy (NST). Methods: Patients with cT1-4N0-3 breast cancer treated with NST (2006–2016) were selected from the Netherlands Cancer Registry. Patients were classified by clinical node status (cN) and type of axillary surgery. Uni- and multivariable logistic regression analyses were performed to determine the clinicopathological factors associated with performing ALND in cN+ patients. Results: A total of 12,461 patients treated with NST were identified [5830 cN0 patients (46.8%), 6631 cN+ patients (53.2%)]. In cN0 patients, an overall increase in sentinel lymph node biopsy (SLNB) only (not followed by ALND) was seen from 11% in 2006 to 94% in 2016 (p < 0.001). SLNB performed post-NST increased from 33 to 62% (p < 0.001). In cN+ patients, an overall decrease in ALND was seen from 99% in 2006 to 53% in 2016 (p < 0.001). Age (OR 1.01, CI 1.00–1.02), year of diagnosis (OR 0.47, CI 0.44–0.50), HER2-positive disease (OR 0.62, CI 0.52–0.75), clinical tumor stage (T2 vs. T1 OR 1.32, CI 1.06–1.65, T3 vs. T1 OR 2.04, CI 1.58–2.63, T4 vs. T1 OR 6.37, CI 4.26–9.50), and clinical nodal stage (N3 vs. N1 OR 1.65, CI 1.28–2.12) were correlated with performing ALND in cN+ patients. Conclusions: ALND decreased substantially over the past decade in patients treated with NST. Assessment of long-term prognosis of patients in whom ALND is omitted after NST is urgently needed.

Original languageEnglish
Pages (from-to)725-733
Number of pages9
JournalBreast Cancer Research and Treatment
Volume180
Issue number3
DOIs
Publication statusPublished - 1 Apr 2020

Bibliographical note

Funding Information:
The authors thank the registration clerks and the staff for gathering the data for the NCR and L. de Munck and S.J. Hogewoning for assistance with statistical analysis. JM Simons received salary from the Dutch Cancer Society (KWF Kankerbestrijding).

Publisher Copyright:
© 2020, The Author(s).

Fingerprint

Dive into the research topics of 'De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study'. Together they form a unique fingerprint.

Cite this